All In Biotech

Drug Trial Radar · NCT04999527

Study to Evaluate the Safety, Tolerability, PK and PD of DISC-0974 in Healthy Subjects

A Phase 1, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, PK and PD of DISC-0974 in Healthy Subjects Following Dose-Escalating Single Intravenous or Subcutaneous Administration

Last checked: Nov 19, 2026Latest source record: Jul 19, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

42

Actual

Start

Aug 10, 2021

Primary completion

Jun 30, 2022

Study completion Jun 30, 2022

Sponsor

Lead sponsor
Disc Medicine, IncIndustry
Sponsor type
Industry
First posted
Aug 11, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Sequential
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This Phase 1 study of DISC-0974 will assess the safety, tolerability, pharmacokinetics (PK) and Pharmacodynamics (PD) of DISC-0974 in adult healthy volunteers.

Conditions

  • Healthy Volunteer

Interventions

  • DISC-0974Drug

    DISC-0974 is administered (IV infusion or Subcutaneous Injection) as a single dose

  • PlaceboDrug

    Placebo is administered (IV infusion or Subcutaneous Injection) as a single dose

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence of adverse eventsTime frame: Up to 71 days of monitoring
  2. Incidence of abnormal laboratory test resultsTime frame: Up to 71 days of monitoring
  3. Incidence of treatment-emergent clinically abnormal electrocardiogram (ECG)Time frame: Up to 71 days of monitoring
  4. Incidence of treatment-emergent clinically abnormal physical examTime frame: Up to 71 days of monitoring

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Worldwide Clinical Trials

    San Antonio, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.